Showing results (1-10 of 285) with videos related to
Sort By:
Pageof 29
Current Hypertension Reports|February 3, 2005
Gene markers and antihypertensive therapyStephen T Turner, Gary L SchwartzAmerican Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|June 4, 2004
Pharmacogenetics of antihypertensive drug responsesGary L Schwartz, Stephen T TurnerClinical Chemistry|February 1, 2005
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activityGary L Schwartz, Stephen T TurnerCurrent Treatment Options in Cardiovascular Medicine|July 12, 2005
Treatment of leukoaraiosisGary L Schwartz, Myriam Fornage, Thomas Mosley, et al.Hypertension (Dallas, Tex. : 1979)|September 21, 2005
WNK1 kinase polymorphism and blood pressure response to a thiazide diureticStephen T Turner, Gary L Schwartz, Arlene B Chapman, et al.Kidney International|February 19, 2002
Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertensionArlene B Chapman, Gary L Schwartz, Eric Boerwinkle, et al.American Journal of Hypertension|October 14, 2003
Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazideStephen T Turner, Arlene B Chapman, Gary L Schwartz, et al.Kidney International|October 10, 2002
Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazideGary L Schwartz, Stephen T Turner, Arlene B Chapman, et al.Physiological Genomics|July 9, 2009
Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA studyMaja Barbalic, Gary L Schwartz, Arlene B Chapman, et al.American Journal of Hypertension|April 18, 2013
The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertensionGary L Schwartz, Kent Bailey, Arlene B Chapman, et al.Pageof 29